Feasibility study of VERAFEYE system for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This study tests whether a new imaging and guidance system, VERAFEYE, can help doctors perform catheter ablation for atrial fibrillation. It is designed for people with paroxysmal or persistent AF who are already scheduled for this procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 22 years or older.
- You have been diagnosed with paroxysmal or persistent atrial fibrillation.
- You are scheduled to have a catheter ablation procedure for AF.
- You do not have certain heart conditions like a pacemaker, severe valve disease, or prior atrial ablation.
- Your heart function is within acceptable limits, with a left ventricular ejection fraction of 40% or higher.
- You have no blood clotting problems or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers a new imaging and guidance system called VERAFEYE during catheter ablation for people with paroxysmal atrial fibrillation (a type of irregular heartbeat). It aims to see if the system helps make the procedure safer and more effective.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.